UCLA Health
Los Angeles, California 90404
11 studies enrolling now · 32 studies all time
What they study most
AOSD, Acute Pulmonary Embolism, Adult Growth Hormone Deficiency, Advanced Cancer, Alzheimer Disease, Arrhythmia, Atopic Dermatitis, Cancer, Cardiomyopathy, Chest Pain With Normal Coronary Angiography, Chronic Disease, Coronary Microvascular Dysfunction
Studies at this site
- A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer — Recruiting now
- Pancreatic Cancer Early Detection Consortium — Recruiting now
- A Gaucher Disease Gene Therapy Trial With FLT201 — Recruiting now
- A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease — Recruiting now
- A Phase 2 Study of YA-101 in Patients With Multiple System Atrophy — Recruiting now
- Treatment of Refractory Infantile Spasms With Fenfluramine — Recruiting now
- A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors — Recruiting now
- A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors — Recruiting now
- Brown Adipose Tissue Activity in Response to Semaglutide Administered to Obese Subjects. — Recruiting now
- A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV) — Running, not enrolling
- Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program — Completed
- Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma — Starting soon
- A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP) — Running, not enrolling
- A Study to Follow Patients With Adult Growth Hormone Deficiency (AGHD) Treated With Sogroya® for Long Term Safety Information — Enrolling by invitation
- GORE® CARDIOFORM Septal Occluder Migraine Clinical Study — Stopped early
- Increasing the Feasibility, Impact, and Equity of the Medicare Annual Wellness Visit (AWV) — Running, not enrolling
- Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE — Completed
- The DISCOVER INOCA Prospective Multi-center Registry — Running, not enrolling
- Allergic Disease Onset Prevention Study — Completed
- Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes — Paused
- Optimization of VNS in Epileptic Patients to Induce Cardioprotection — Completed
- PAK4 and NAMPT in Patients With Solid Malignancies or NHL (PANAMA) — Stopped early
- A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors — Completed
- An Electronic Clinical Decision Support Tool to Reduce Low-value Antipsychotic Prescriptions — Completed
- Using Behavioral Economics to Reduce Low-Value Care — Completed
- Evaluating the Safety and Efficacy of the AlphaVac Multipurpose Mechanical Aspiration (MMA) F1885 PE for Treatment of Acute Pulmonary Embolism — Completed
- Mindfulness in Post Acute Sequelae of SARS-CoV-2 Infection (PASC) Dysautonomia — Completed
- ACS Community Access to Resources Education and Support — Status unconfirmed
- Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias — Status unconfirmed
- A Study to Evaluate the Effect of Vagus Nerve Stimulation in Patients Undergoing VT Ablation — Completed
- Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer — Completed
- Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy — APPROVED_FOR_MARKETING